Cover Image
市場調查報告書

PharmaPoint:異位性皮膚炎--現在與未來市場參與企業

Atopic Dermatitis - Current and Future Players

出版商 GlobalData 商品編碼 293251
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
PharmaPoint:異位性皮膚炎--現在與未來市場參與企業 Atopic Dermatitis - Current and Future Players
出版日期: 2015年11月03日 內容資訊: 英文 58 Pages
簡介

本報告提供全球的異位性皮膚炎相關市場上現有企業及新加入企業相關分析、整體市場的未來展望和促進、阻礙因素、現在與未來的競爭趨勢,再加上主要企業簡介(營業內容、策略、業績、SWOT分析)等調查資料、考察,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

  • 分析的背景
  • 相關調查
  • 出版預定的相關調查

第3章 市場預測

  • 全球市場
    • 市場預測
    • 全球市場的促進、阻礙因素

第4章 現在、未來市場參與企業

  • 概要
  • 企業策略的趨勢
  • 企業簡介
    • Astellas Pharma Inc.
    • Meda
    • Regeneron
    • Anacor

第5章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC1050FPR

GlobalData has released its pharma report, "Atopic Dermatitis - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Atopic Dermatitis Market. The report identifies and analyses the key companies shaping and driving the global Atopic Dermatitis market. The report provides insight into the competitive Atopic Dermatitis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Atopic Dermatitis
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Atopic Dermatitis sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving Atopic Dermatitis market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What's the next big thing in the global Atopic Dermatitis market landscape? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Market Outlook

  • 3.1. Global Markets
    • 3.1.1. Forecast
    • 3.1.2. Global Drivers and Barriers

4. Current and Future Players

  • 4.1. Overview
  • 4.2. Trends in Corporate Strategy
  • 4.3. Company Profiles
    • 4.3.1. Astellas
    • 4.3.2. Meda
    • 4.3.3. Sanofi/Regeneron/Boehringer Ingelheim
    • 4.3.4. Anacor

5. Appendix

  • 5.1. Bibliography
  • 5.2. Abbreviations
  • 5.3. Methodology
  • 5.4. Forecasting Methodology
    • 5.4.1. Diagnosed Atopic Dermatitis Patients
    • 5.4.2. Percent Drug-treated Patients
    • 5.4.3. Drugs Included in Each Therapeutic Class
    • 5.4.4. Launch and Patent Expiry Dates
    • 5.4.5. General Pricing Assumptions
    • 5.4.6. Individual Drug Assumptions
    • 5.4.7. Generic Erosion
    • 5.4.8. Pricing of Pipeline Agents
  • 5.5. Physicians and Specialists Included in this Study
  • 5.6. Primary Research - Prescriber Survey
  • 5.7. About the Authors
    • 5.7.1. Author
    • 5.7.2. Reviewer
    • 5.7.3. Epidemiologist
    • 5.7.4. Global Director of Therapy Analysis and Epidemiology
    • 5.7.5. Global Head of Healthcare
  • 5.8. About GlobalData
  • 5.9. Disclaimer

List of Tables

  • Table 1: Global Sales Forecasts ($m) for Atopic Dermatitis, 2014-2024
  • Table 2: Global Atopic Dermatitis Market - Drivers and Barriers, 2014-2024
  • Table 3: Key Companies in the Atopic Dermatitis Market, 2015
  • Table 4: Astellas Pharma's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 5: Astellas Pharma SWOT Analysis, 2015
  • Table 6: Meda's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 7: Meda SWOT Analysis, 2015
  • Table 8: Regeneron's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 9: Regeneron SWOT Analysis, 2015
  • Table 10: Anacor's Atopic Dermatitis Portfolio Assessment, 2015
  • Table 11: Anacor's SWOT Analysis, 2015
  • Table 12: Key Launch Dates
  • Table 13: Key Patent Expiries
  • Table 14: Physicians Surveyed, By Country

List of Figures

  • Figure 1: Global Sales for Atopic Dermatitis by Region, 2012-2022
  • Figure 2: Company Portfolio Gap Analysis in Atopic Dermatitis, 2014-2024
Back to Top